Reuters logo
BRIEF-Medibeacon completes successful clinical study of transdermal glomerular filtration rate monitor on impaired kidney function subjects
March 2, 2017 / 1:58 PM / 7 months ago

BRIEF-Medibeacon completes successful clinical study of transdermal glomerular filtration rate monitor on impaired kidney function subjects

March 2 (Reuters) - Hc2 Holdings Inc

* Medibeacon completes successful clinical study of transdermal glomerular filtration rate monitor on impaired kidney function subjects

* Medibeacon says anticipate beginning multicenter clinical study including sites in United States and Europe during Q4 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below